Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases

The purpose of this study is to collect blood samples to detect potential markers of pancreatic cancer in the blood and link these findings to medical and health information. Information from this study may help to provide insight into the detection of pancreas cancer in the blood before it can be found by other methods or provide a method of monitoring the status of pancreatic cancer throughout a treatment course. Another purpose of this study is to collect blood to create a biobank.

Enrolling by invitation

Interested in participating?

Request Info

Key information

Conditions

Pancreatic Diseases Digestive System Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The subject must be a patient at the Hospital of the University of Pennsylvania

The subject must be under evaluation and/or treatment for a pancreatic disease
The subject must be under evaluation and/or treatment for a non-pancreatic disease. For example, patients undergoing routine colonoscopy within the clinical practice will be asked to consent to provide control samples.
The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf
The subject must be 18 years of age or older

Exclusion criteria

The subject or acceptable surrogate does not provide informed consent
Subject is a prisoner
Subject is under 18 years of age

Treatment and study plan

Primary outcomes

Collection of blood and tissue samples from subjects with pancreatic diseases

Time frame: 3 years

Interested in participating?

Enrolling by invitation

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

Abramson Cancer Center at Penn Medicine

Other

Registry information

Important dates

Study start: 2015
Primary completion: 2035
Study completion: 2035
First posted: Jun 15, 2015
Registry last updated: Jul 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting